Medtronic PLC

MDT Healthcare Medical Devices

Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025. In the quarter to July 2026, revenue grew 13.7%, EPS grew 42.0%, free cash flow grew 120.9% and total debt fell 1.59%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three.

94.75 0.70 −0.73%
Market cap
$122.1B
P/E
23.2×
Fwd P/E
18.7×
Dividend yield
3.02%
F-score
7/9
Altman Z
2.73
Beneish M
−2.58
Dividend safety
61/100

Medtronic PLC (MDT) Revenue growth

Alert me on Revenue growth

Medtronic PLC's revenue growth over the twelve months to 31 July 2026 was 9.77%, up 1.3 percentage points from fiscal 2026 (8.43%). Over the past ten years it has ranged from −5.38% (fiscal 2020) to 42.3% (fiscal 2016); the current reading is higher than 83% of that period. That is above the Medical Devices industry median of 8.80% and above the Healthcare sector median of 8.27%.

Revenue growth, annual

Embed this chart

Annual newest first

Period Revenue growth Change (points)
FY2026 8.43% 4.81
FY2025 3.62% (0.02)
FY2024 3.64% 5.09
FY2023 −1.45% (6.66)
FY2022 5.21% 1.05
FY2021 4.16% 9.54
FY2020 −5.38% (7.40)
FY2019 2.02% 1.20
FY2018 0.82% (2.22)
FY2017 3.04% (39.27)

Quarterly newest first

Period Revenue growth Change (points)
Jul 2026 13.7% 3.86
Apr 2026 9.87% 1.13
Jan 2026 8.74% 2.10
Oct 2025 6.64% (1.74)
43 more quarters

Against its own ten years

Low −5.38% High 42.3%
Ten-year median 3.63%
Current reading's percentile 83

Revenue growth against peers

What Revenue growth is

Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.

(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|

The full definition of Revenue growth →

More on MDT